Literature DB >> 22432082

Vav1 in hematologic neoplasms, a mini review.

Matthew J Oberley1, Deng-Shun Wang, David T Yang.   

Abstract

The Vav family of proteins are guanine nucleotide exchange factors which have been shown to be deregulated in several types of human cancer. There are three members of the Vav family that have been identified which are members of the Dbl domain superfamily and have specificity towards Rho/Rac GTPases. The Vav family plays an important role in normal hematologic system development and homeostasis, and Vav1 is largely restricted to the hematologic system. While Vav1 was originally identified as a proto-oncogene, several recent studies have shown that Vav family deletion leads to the development of T-cell malignancies in mice. In addition, Vav1 has been shown to play a role in the ATRA-mediated differentiation of promyelocytic leukemia cells. In this concise review, the gene structure and normal function of Vav1, as well as a possible role for Vav1 in the development of hematologic and other malignancies is reviewed.

Entities:  

Keywords:  Vav1; guanine nucleotide exchange factor; leukemia; lymphoma

Year:  2012        PMID: 22432082      PMCID: PMC3301436     

Source DB:  PubMed          Journal:  Am J Blood Res        ISSN: 2160-1992


  41 in total

1.  Tyrosine residues at the carboxyl terminus of Vav1 play an important role in regulation of its biological activity.

Authors:  Galit Lazer; Liron Pe'er; Marganit Farago; Kazuya Machida; Bruce J Mayer; Shulamit Katzav
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  Role of scaffold protein afadin dilute domain-interacting protein (ADIP) in platelet-derived growth factor-induced cell movement by activating Rac protein through Vav2 protein.

Authors:  Yuri Fukumoto; Souichi Kurita; Yoshimi Takai; Hisakazu Ogita
Journal:  J Biol Chem       Date:  2011-10-25       Impact factor: 5.157

3.  Vav promotes differentiation of human tumoral myeloid precursors.

Authors:  Valeria Bertagnolo; Federica Brugnoli; Carlo Mischiati; Alessia Sereni; Alberto Bavelloni; Cinzia Carini; Silvano Capitani
Journal:  Exp Cell Res       Date:  2005-03-17       Impact factor: 3.905

4.  Leukemia-associated Rho guanine nucleotide exchange factor, a Dbl family protein found mutated in leukemia, causes transformation by activation of RhoA.

Authors:  G W Reuther; Q T Lambert; M A Booden; K Wennerberg; B Becknell; G Marcucci; J Sondek; M A Caligiuri; C J Der
Journal:  J Biol Chem       Date:  2001-05-23       Impact factor: 5.157

5.  Cell of origin strongly influences genetic selection in a mouse model of T-ALL.

Authors:  Katherine E Berquam-Vrieze; Kishore Nannapaneni; Benjamin T Brett; Linda Holmfeldt; Jing Ma; Oksana Zagorodna; Nancy A Jenkins; Neal G Copeland; David K Meyerholz; C Michael Knudson; Charles G Mullighan; Todd E Scheetz; Adam J Dupuy
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

Review 6.  Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies.

Authors:  Jon C Aster; Stephen C Blacklow; Warren S Pear
Journal:  J Pathol       Date:  2010-10-21       Impact factor: 7.996

7.  Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product.

Authors:  P Crespo; K E Schuebel; A A Ostrom; J S Gutkind; X R Bustelo
Journal:  Nature       Date:  1997-01-09       Impact factor: 49.962

8.  Wound healing defect of Vav3-/- mice due to impaired {beta}2-integrin-dependent macrophage phagocytosis of apoptotic neutrophils.

Authors:  Anca Sindrilaru; Thorsten Peters; Jürgen Schymeinsky; Tsvetelina Oreshkova; Honglin Wang; Anne Gompf; Francesca Mannella; Meinhard Wlaschek; Cord Sunderkötter; Karl Lenhard Rudolph; Barbara Walzog; Xosé R Bustelo; Klaus D Fischer; Karin Scharffetter-Kochanek
Journal:  Blood       Date:  2009-01-15       Impact factor: 22.113

9.  Rac GTPases play critical roles in early T-cell development.

Authors:  Celine Dumont; Agnieszka Corsoni-Tadrzak; Sandra Ruf; Jasper de Boer; Adam Williams; Martin Turner; Dimitris Kioussis; Victor L J Tybulewicz
Journal:  Blood       Date:  2008-12-16       Impact factor: 22.113

Review 10.  Flesh and blood: the story of Vav1, a gene that signals in hematopoietic cells but can be transforming in human malignancies.

Authors:  Shulamit Katzav
Journal:  Cancer Lett       Date:  2007-06-21       Impact factor: 8.679

View more
  10 in total

1.  Pak and Rac GTPases promote oncogenic KIT-induced neoplasms.

Authors:  Holly Martin; Raghuveer Singh Mali; Peilin Ma; Anindya Chatterjee; Baskar Ramdas; Emily Sims; Veerendra Munugalavadla; Joydeep Ghosh; Ray R Mattingly; Valeria Visconte; Ramon V Tiu; Cornelis P Vlaar; Suranganie Dharmawardhane; Reuben Kapur
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

2.  Transposon mutagenesis reveals cooperation of ETS family transcription factors with signaling pathways in erythro-megakaryocytic leukemia.

Authors:  Jian Zhong Tang; Catherine L Carmichael; Wei Shi; Donald Metcalf; Ashley P Ng; Craig D Hyland; Nancy A Jenkins; Neal G Copeland; Viive M Howell; Zhizhuang Joe Zhao; Gordon K Smyth; Benjamin T Kile; Warren S Alexander
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-26       Impact factor: 11.205

3.  Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas.

Authors:  Francesco Abate; Ana C da Silva-Almeida; Sakellarios Zairis; Javier Robles-Valero; Lucile Couronne; Hossein Khiabanian; S Aidan Quinn; Mi-Yeon Kim; Maria Antonella Laginestra; Christine Kim; Danilo Fiore; Govind Bhagat; Miguel Angel Piris; Elias Campo; Izidore S Lossos; Olivier A Bernard; Giorgio Inghirami; Stefano Pileri; Xosé R Bustelo; Raul Rabadan; Adolfo A Ferrando; Teresa Palomero
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-06       Impact factor: 11.205

4.  Cross-species epigenetics identifies a critical role for VAV1 in SHH subgroup medulloblastoma maintenance.

Authors:  J C Lindsey; D Kawauchi; E C Schwalbe; D J Solecki; M P Selby; P J McKinnon; J M Olson; J T Hayden; R G Grundy; D W Ellison; D Williamson; S Bailey; M F Roussel; S C Clifford
Journal:  Oncogene       Date:  2014-12-22       Impact factor: 9.867

Review 5.  Vav1: A Dr. Jekyll and Mr. Hyde protein--good for the hematopoietic system, bad for cancer.

Authors:  Shulamit Katzav
Journal:  Oncotarget       Date:  2015-10-06

6.  Large-Scale Proteomic Analysis of Follicular Lymphoma Reveals Extensive Remodeling of Cell Adhesion Pathway and Identifies Hub Proteins Related to the Lymphomagenesis.

Authors:  Kamila Duś-Szachniewicz; Grzegorz Rymkiewicz; Anil Kumar Agrawal; Paweł Kołodziej; Jacek R Wiśniewski
Journal:  Cancers (Basel)       Date:  2021-02-05       Impact factor: 6.639

Review 7.  Vav Proteins in Development of the Brain: A Potential Relationship to the Pathogenesis of Congenital Zika Syndrome?

Authors:  Aidan J Norbury; Lachlan A Jolly; Luke P Kris; Jillian M Carr
Journal:  Viruses       Date:  2022-02-14       Impact factor: 5.048

Review 8.  The adaptor protein Crk in immune response.

Authors:  Dongfang Liu
Journal:  Immunol Cell Biol       Date:  2013-10-29       Impact factor: 5.126

Review 9.  Chaperone-mediated autophagy substrate proteins in cancer.

Authors:  Ying Tang; Xiong-Wen Wang; Zhan-Hua Liu; Yun-Ming Sun; Yu-Xin Tang; Dai-Han Zhou
Journal:  Oncotarget       Date:  2017-05-03

10.  Vav1 Promotes B-Cell Lymphoma Development.

Authors:  Batel Shalom; Marganit Farago; Yaser Salaymeh; Shulamit Sebban; Eli Pikarsky; Shulamit Katzav
Journal:  Cells       Date:  2022-03-10       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.